INmune Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.
INMB Key Statistics
Stock Snapshot
The current INmune Bio(INMB) stock price is $1.56, with a market capitalization of 41.21M. The stock trades at a price-to-earnings (P/E) ratio of -0.91.
During the trading session on 2026-05-15, INmune Bio(INMB) shares reached a daily high of $1.68 and a low of $1.54. At a current price of $1.56, the stock is +1.3% higher than the low and still -7.1% under the high.
Trading activity shows a volume of 869.46K, compared to an average daily volume of 673.53K.
Over the past 52 weeks, INmune Bio(INMB) stock has traded between a high of $11.64 and a low of $1.09.
Over the past 52 weeks, INmune Bio(INMB) stock has traded between a high of $11.64 and a low of $1.09.
INMB News
INmune Bio (INMB) announced that results from its Phase 2 MINDFuL trial in Alzheimer’s disease have been published in the peer-reviewed journal NPJ Dementia. Th...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Inmune Bio ((INMB)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.